Claims for Patent: 5,645,814

Summary for Patent: 5,645,814

Title:	Hexadentate complexes useful in radiographic imaging agents
Abstract:	The present invention relates particularly to novel preorganized hexadentate ligands that are suitable for complexing with a radionuclide, and are useful as general imaging agents for diagnostic purposes.
Inventor(s):	Woulfe; Steven R. (Ballwin, MO), Rajagopalan; Raghavan (Maryland Heights, MO)
Assignee:	Mallinckrodt Medical, Inc., (St. Louis, MO)
Application Number:	08/229,037
Patent Claims:	1. A radionuclide complex having the general formula: ##STR7## wherein M is a radionuclide; and wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and are selected from the group consisting of hydrogen, alkyl, aryl, hydroxyl, alkoxyl, mono- or poly- hydroxyalkyl, mono- or poly- alkoxyalkyl, alkoxycarbonyl or carbamoyl; l and m may be the same or different and are from 1 to 6; Q and Z may be the same or different and are an O, N or S atom; and X and Y are --P(R.sub.4)R.sub.5 wherein R.sub.4 and R.sub.5 may be the same or different and are selected from the group consisting of hydrogen, methyl, ethyl, and aryl groups. 2. A complex according to claim 1, wherein M is technetium or rhenium. 3. The radionuclide complex of claim 1 wherein R.sub.4 and R.sub.5 are selected from the group consisting of phenyl and benzyl groups. 4. A complex according to claim 1, wherein R.sub.1 is hydrogen; R.sub.2 and R.sub.3 are methyl groups; l and m are 3; and Q and Z are oxygen atoms. 5. The radionuclide complex of claim 4 wherein R.sub.4 and R.sub.5 are selected from the group consisting of phenyl and benzyl groups. 6. A radiographic imaging agent comprising a complex having the general formula: ##STR8## wherein M is a radionuclide; and wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and are selected from the group consisting of hydrogen, alkyl, aryl, hydroxyl, alkoxyl, mono- or poly- hydroxyalkyl, mono- or poly- alkoxyalkyl, alkoxycarbonyl or carbamoyl; l and m may be the same or different and are from 1 to 6; Q and Z may be the same or different and are an O, N or S atom; and X and Y are --P(R.sub.4)R.sub.5 wherein R.sub.4 and R.sub.5 may be the same or different and are selected from the group consisting of hydrogen, methyl, ethyl, and aryl groups; and a pharmaceutically acceptable radiological vehicle. 7. An imaging agent according to claim 6, wherein M is technetium or rhenium. 8. The radiographic imaging agent of claim 6 wherein R.sub.4 and R.sub.5 are selected from the group consisting of phenyl and benzyl groups. 9. An imaging agent according to claim 6, wherein said vehicle is suitable for injection or aspiration and is selected from the group consisting of human serum albumin, aqueous buffer solutions, sterile water, physiological saline, and balanced ionic solutions containing chloride salts, dicarbonate salts or blood plasma cations. 10. An imaging agent according to claim 6, wherein the concentration of said complex in said vehicle is from about 1.0 to 50 millicuries. 11. A method of radiographic imaging, comprising injecting a sufficient amount of an imaging agent to provide adequate imaging and then scanning with a suitable scanning machine; said imaging agent comprising a complex having the general formula: ##STR9## wherein M is a radionuclide; and wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and are selected from the group consisting of hydrogen, alkyl, aryl, hydroxyl, alkoxyl, mono- or poly- hydroxyalkyl, mono- or poly- alkoxyalkyl, alkoxycarbonyl or carbamoyl; l and m may be the same or different and are from 1 to 6; Q and Z may be the same or different and are an O, N or S atom; and X and Y are --P(R.sub.4)R.sub.5 wherein R.sub.4 and R.sub.5 may be the same or different and are selected from the group consisting of hydrogen, methyl, ethyl, and aryl groups; and a pharmaceutically acceptable radiological vehicle. 12. A method of imaging according to claim 11, wherein M is technetium or rhenium. 13. The method of claim 11 wherein R.sub.4 and R.sub.5 are selected from the group consisting of phenyl and benzyl groups. 14. A method of imaging according to claim 11, wherein said vehicle is suitable for injection or aspiration and is selected from the group consisting of human serum albumin, aqueous buffer solutions, sterile water, physiological saline, and balanced ionic solutions containing chloride salts, dicarbonate salts or blood plasma cations. 15. A method of imaging according to claim 11, wherein the concentration of said complex in said vehicle is from about 1.0 to 50 millicuries.

Details for Patent 5,645,814

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2014-07-08